Drug Approval | June 17, 2024
Imfinzi approved in the US for endometrial cancer
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
EDQM has also issued a Certificate of Suitability for Allopurino
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Subscribe To Our Newsletter & Stay Updated
